Citigroup Inc news

   Watch this stock
Showing stories 1 - 10 of about 113   

Articles published

C 51.00 -0.19 (-0.37%)
price chart
Citigroup Inc Reports On Law Firms' Cyber Attacks
Citigroup Inc warns its employees of potential cyber-attacks on law firms' websites and networks. It has been a common practice by US companies to publish reports of being targeted by hackers that steel sensitive information of corporate clients.
Citigroup Inc Closing In Sale Of Japanese Card Unit
Inside sources claimed that Citigroup Inc (NYSE:C) was in the final round of talks to divest its credit card unit in Japan.
Citigroup Said to Be Close to Sale of Japanese Card Unit  Bloomberg
Bank Stock Roundup: Streamlining & Litigations Continue; Citigroup ...  Nasdaq
Inovalon Holdings Given New $33.00 Price Target at Citigroup Inc. (INOV)
Inovalon Holdings (NASDAQ:INOV) had its price objective raised by Citigroup Inc. from $31.00 to $33.00 in a research report released on Thursday morning.
EV Energy Partners, L.P. PT Lowered to $17.50 at Citigroup Inc. (EVEP)
EV Energy Partners, L.P. logo EV Energy Partners, L.P. (NASDAQ:EVEP) had its price objective decreased by Citigroup Inc. from $36.00 to $17.50 in a report released on Thursday.
SunCoke Energy Partners Stock Rating Upgraded by Citigroup Inc. (SXCP)  The Legacy
Citigroup Inc. Reiterates "Sell" Rating for BlackBerry (BBRY)
BlackBerry logo BlackBerry (NASDAQ:BBRY)'s stock had its �sell� rating reiterated by equities researchers at Citigroup Inc. in a research report issued on Friday. Shares of BlackBerry (NASDAQ:BBRY) traded up 1.72% during mid-day trading on Friday ...
BlackBerry Given Sell Rating at Citigroup Inc. (BBRY)  WKRB News
Citigroup Inc. Downgrades Epizyme to Neutral (EPZM)
Epizyme (NASDAQ:EPZM) was downgraded by research analysts at Citigroup Inc. from a �buy� rating to a �neutral� rating in a report released on Friday, TheFlyOnTheWall.
Epizyme Lowered to "Neutral" at Citigroup Inc. (EPZM)  Mideast Time
Epizyme Lowered to Neutral at Citigroup Inc. (EPZM)  sleekmoney
Citigroup Inc. Initiates Coverage on The Medicines Company (MDCO)
The Medicines Company logo Research analysts at Citigroup Inc. began coverage on shares of The Medicines Company (NASDAQ:MDCO) in a report released on Friday.
Shares of Citigroup Inc. Are Up, but There May Be More Gains Ahead
During the past six weeks or so, Citigroup (NYSE: C ) shares have risen from around $47 to $53 as of this writing, a gain of about 13%.
Citigroup CCAR: Further Stress Or Sigh Of Relief? (C)  Seeking Alpha (registration)
Citigroup Inc. (NYSE:C) Update: Citi releases results of 2015 Dodd-Frank ...  Markets Bureau
Stock Analysis on Citigroup Inc. (NYSE:C)
[Business Wire] Citigroup Inc. (NYSE:C)(TREND ANALYSIS) and Trade Solutions has won the 2015 Celent Model Bank award for innovation, effective use of technology and integration excellence for the CitiConnect ERP Integrator.
Citigroup Inc. Trims Atlas Resource Partners, LP Target Price to $8.00 (ARP)
Atlas Resource Partners, L.P. logo Atlas Resource Partners, L.P. (NYSE:ARP) had its price objective trimmed by Citigroup Inc. from $21.00 to $8.00 in a research report released on Thursday morning. Citigroup Inc. currently has a neutral rating on the ...
Atlas Resource Partners, L.P. To Go Ex-Dividend on April 2nd (ARP)  sleekmoney